Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Z Leder

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 2, 2019
Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With OsteoporosisBenjamin Z Leder, Bruce Mitlak, Ming-Yi Hu, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|June 19, 2017
Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled TrialJoy N Tsai, Linda A Jiang, Hang Lee, et al.
JBMR Plus|October 27, 2025
The comparative efficacy of 12-mo of alendronate and raloxifene in maintaining denosumab-induced improvement in peripheral volumetric BMD, microarchitecture, and estimated strengthBenjamin Z Leder, Joy N Tsai, Sabashini K Ramchand, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Differential effects of androgens and estrogens on bone turnover in normal menBenjamin Z Leder, Karen M LeBlanc, David A Schoenfeld, et al.
Clinical Endocrinology|January 27, 2005
Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levelsRyan H Dougherty, Jacqueline L Rohrer, Douglas Hayden, et al.
Endocrinology|October 24, 2024
Evaluation of Osteogenic Phenotype in Postmenopausal Women Receiving Anabolic and Antiresorptive Osteoporosis TherapiesMargaret M Kobelski, Sabashini K Ramchand, Joy N Tsai, et al.
Steroids|May 9, 2002
Effects of androstenedione administration on epitestosterone metabolism in menDon H Catlin, Benjamin Z Leder, Brian D Ahrens, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2023
Safety of Inpatient Zoledronic Acid in the Immediate Postfracture SettingWuQiang Fan, Benjamin Z Leder, Michael Mannstadt, et al.
Bone|May 10, 2016
Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmeticsBenjamin Z Leder, Joy N Tsai, Sherri-Anne Burnett-Bowie, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 28, 2021
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study ExtensionSabashini K Ramchand, Natalie L David, Hang Lee, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|November 2, 2019
Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With OsteoporosisBenjamin Z Leder, Bruce Mitlak, Ming-Yi Hu, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|June 19, 2017
Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled TrialJoy N Tsai, Linda A Jiang, Hang Lee, et al.
JBMR Plus|October 27, 2025
The comparative efficacy of 12-mo of alendronate and raloxifene in maintaining denosumab-induced improvement in peripheral volumetric BMD, microarchitecture, and estimated strengthBenjamin Z Leder, Joy N Tsai, Sabashini K Ramchand, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Differential effects of androgens and estrogens on bone turnover in normal menBenjamin Z Leder, Karen M LeBlanc, David A Schoenfeld, et al.
Clinical Endocrinology|January 27, 2005
Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levelsRyan H Dougherty, Jacqueline L Rohrer, Douglas Hayden, et al.
Endocrinology|October 24, 2024
Evaluation of Osteogenic Phenotype in Postmenopausal Women Receiving Anabolic and Antiresorptive Osteoporosis TherapiesMargaret M Kobelski, Sabashini K Ramchand, Joy N Tsai, et al.
Steroids|May 9, 2002
Effects of androstenedione administration on epitestosterone metabolism in menDon H Catlin, Benjamin Z Leder, Brian D Ahrens, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2023
Safety of Inpatient Zoledronic Acid in the Immediate Postfracture SettingWuQiang Fan, Benjamin Z Leder, Michael Mannstadt, et al.
Bone|May 10, 2016
Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmeticsBenjamin Z Leder, Joy N Tsai, Sherri-Anne Burnett-Bowie, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 28, 2021
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study ExtensionSabashini K Ramchand, Natalie L David, Hang Lee, et al.
Pageof 9